
Firm Files Cert. Reply on Behalf of DeAndre Gordon
Today, the firm filed the Cert. Reply in Gordon v. May, No. 23-629 (U.S.), urging the Supreme Court to review a legal question that respondent acknowledges has deeply divided the federal courts of appeals 4 to 7.

Firm Files Amicus Brief For NAPD And MACDL In Support Of Petitioner Carlos Guardado
Today, Daniel Woofter filed an Amici Curiae Brief on behalf of NAPD and MACDL in Guardado v. Massachusetts, No. 23-886 (U.S.), urging the Supreme Court to review whether there is an exception to its double jeopardy jurisprudence that gives the prosecution a second trial in which to supply missing evidence when there was a change in the law after the first proceeding was complete.

Firm Files Cert. Reply on Behalf of Petitioner Atif Rafay
Today, Daniel and Kevin filed the Cert. Reply in Rafay v. Jackson, No. 23-636 (U.S.), seeking a summary reversal from the Supreme Court for the Ninth Circuit to consider a habeas claim the panel overlooked—that Atif’s conviction was premised on a confession coerced by police tactics that are inherently coercive.


Firm Files Cert.-Stage Amicus Brief on Behalf of NAPD
Today, Daniel Woofter filed an Amicus Curiea Brief on behalf of the National Association for Public Defense in support of the petitioner in Delligatti v. United States, No. 23-825 (U.S.), arguing that a prior conviction cannot be a predicate “crime of violence” under the use-of-force clause of Section 924(c) of the Armed Career Criminal Act if the crime of conviction can be accomplished with no physical action whatsoever.

Firm Represents Plaintiffs in Related Qui Tam Appeals Before the D.C. Circuit
Daniel Woofter represents the qui tam plaintiffs in related appeals pending before the D.C. Circuit, with oral argument set for April 1st. The Opening Brief in United States of America ex rel. O’Connor v. U.S. Cellular Corp., No. 23-7401, and the Opening Brief in related appeal No. 23-7044 were filed in October of last year. The Reply Brief in No. 23-7401 and the Reply Brief in No. 23-7044 were filed January 19 of this year.

Firm Files Cert. Opposition In Copyright Case With Harvard Supreme Court Litigation Clinic
Recently the Firm filed a Brief in Opposition to the Cert. Petition in Hasbro, Inc. v. Markham Concepts, No. 23-565 (U.S.), a copyright case arising from a dispute over authorship of the popular Game of Life.
Photo by Randy Fath.

Firm Files Second Cert. Petition in Escobar v. Texas With Help of Harvard Supreme Court Litigation Clinic
Last Friday, the firm filed a second Cert. Petition from state habeas in Escobar v. Texas, No. 23-934 (U.S.), a capital case in which the U.S. Supreme Court granted the Firm’s previous Cert. Petition on behalf of Mr. Escobar, vacated the judgment, and remanded to the Texas Court of Criminal Appeals for further consideration in light of the State’s confession of error.

Firm Files Second Circuit Reply in Case Alleging Conspiracy Among Banks To Manipulate The Price Benchmark For Silver
On February 21st, the firm filed the Reply Brief in In re: London Silver Fixing, Ltd., No. 23-929 (2d Cir.), a case alleging a conspiracy among large banks to manipulate a precious metals price benchmark so they could reap supracompetitive profits in both the spot and futures markets for silver bullion.

Opening Brief Filed in Trade Dress Infringement Case Before the Second Circuit
Last Wednesday, Daniel Woofter filed the Opening Brief in The Wonderful Company LLC v. Nut Cravings, Inc., No. 23-7540 (2d Cir.), in a case alleging trade dress infringement under the Lanham Act.

Firm Files Cert. Petition Involving “Certificate of Appealability” Standard in AEDPA
On December 7, 2023, the Firm filed a cert. petition in Gordon v. May, No. 23-629 (U.S.), asking the Supreme Court to resolve an entrenched circuit split over the standard that a state prison must meet to appeal the denial of his federal habeas petition.

Firm Petitions SCOTUS on Behalf of Atif Rafay
On December 3, 2023, the firm filed the Cert. Petition in Rafay v. Jackson, No. 23-636 (U.S.), in a case that was the subject of the inaugural episodes of the acclaimed Netflix documentary series “The Confession Tapes,” as well as an episode of Dr. Phil, in which Daniel Woofter appeared on behalf of his client.

Wall Street Journal Story on Firm’s Amicus Brief on Behalf of Former SEC Officials.
The Wall Street Journal has a lengthy story describing the aftermath of the Firm’s Amicus Brief on behalf of former SEC officials in a Second Circuit securities case.
Photo by Waldemar

Firm files Supreme Court Amicus Brief on Behalf of Institutional Investors
On December 20, 2023, the firm filed an Amicus Brief on behalf of institutional investors in Macquarie Infrastructure Corp. v. Moab Partners, L.P., No. 22-1165 (U.S.).

Firm Wins Ninth Circuit Securities Class Action Appeal Against Facebook
On October 18, 2023, the Ninth Circuit ruled in favor of the firm’s clients in a securities class action appeal against Facebook arising from the Cambridge Analytica scandal.

Firm Files Brief on Behalf of Former SEC Officials Urging Rehearing in Securities Case.
On September 13, 2023, the firm filed an Amicus Brief on behalf of former SEC officials urging a Second Circuit panel to rehear an important securities fraud case.

Firm Files Cert. Reply Brief in Steel Tariff Case
Today, the firm filed a reply brief in support of its cert. petition challenging Trump-era steel tariffs.

Firm Files Cert. Reply Brief in Commodity Fraud Case
On August 30, the firm filed its cert. reply brief in Laydon v. Cooperative Rabobank, No. 23-80, a case asking the Supreme Court to address the territorial scope of the Commodity Exchange Act.

Eleventh Circuit Declines to Rehear Firm’s Copyright Victory Against Apple
Today the Eleventh Circuit denied Apple’s petition for rehearing in Apple v. Corellium, a copyright case in which Kevin Russell successfully represented the defendant on appeal.

Opening Brief in Second Circuit Securities Fraud Appeal
Today, the firm partnered with Pomerantz LLP to file the opening brief in an appeal in a securities fraud case involving generic pharmaceutical makers.
Photo by James Yarema